Drug Topics e-News:
Having trouble viewing this email? View in a browser. |
You are subscribed to %%list.name%% as %%emailaddr%%. Unsubscribe.
|
to Drug Topics e-News |
|
|
|
|
Newest: Evolving pharmacy practice in the 21st century
For pharmacists, from Drug Topics: Continuing education for pharmacists and pharmacy technicians. Go to CE site here
|
|
|
|
|
Survey
|
|
This month we would like to know...
As a pharmacist, do you ever advise patients to split pills to save on costs?
* Yes
* No
|
|
|
Patients see greater BP drop with combination therapy at the start
A combination drug therapy given initially appears to result in better blood-pressure control in individuals compared with those who are treated with monotherapy, according to research published online in The Lancet, HealthDay News reported. Read full article. |
|
|
DT Blog
|
A discussion generated by Drug Topics’ readers, editorial staff, and advisory board
Nicole Ebisch, PharmD, CGP |
Pharmacy service: No fries with that
Read full article.
|
|
Medication adherence by elderly after MI is low
Elderly patients have difficulty with long-term adherence to medications following myocardial infarction, and this is significantly worse among those with kidney dysfunction, according to a study published online in the Clinical Journal of the American Society of Nephrology, HealthDay News reported. Read full article. |
|
|
Risk of nontraumatic fractures may rise with use of antiepileptic drugs
Antiepileptic drugs may increase the risk of nontraumatic fractures in patients aged 50 years and older, according to a study published in the Archives of Neurology, HealthDay News reported. Read full article. |
|
|
FDA approves gabapentin once-daily for post-herpetic neuralgia
FDA has approved gabapentin (Gralise, Depomed and Abbott Products) tablets for once-daily treatment of post-herpetic neuralgia. Read full article. |
|
|
FDA gives Contrave complete response letter
FDA has issued a complete response letter for Orexigen’s and Takeda’s Contrave (naltrexone HCl/bupropion HCl) extended-release tablets for the treatment of obesity, including weight loss and maintenance of weight loss. Read full article. |
|
|
Injunction lifted on Allegra-D 24 Hour
Sanofi-aventis is appealing a federal judge's decision to lift the injunction against the sale of a generic Allegra-D 24 Hour product in the United States. Read full article. |
|
|
NACDS urges fairness on HITECH and diabetes supplies
NACDS is urging Congress to make several federal regulations economically viable for retail community pharmacists. Read full article.
|
|
|
|
Wegmans’ pharmacies feature fruit
Empty frozen-fruit bags are the most recent healthy eating display in the pharmacy departments of Wegmans Food Markets. Read full article. |
|
Meetings and Events
February 13, 2011 19th Annual WILLIAM R. BACON MEMORIAL Breakfast
6:30 a.m. - 8:45 a.m.
Palm Springs, CA
Contact:
800-333-7535; 760-325-6611
March 9-10, 2011 NACDS RxIMPACT Day on Capitol Hill
Washington, DC
Contact:
P.O. Box 34814
Alexandria, VA 22334-0814
hecker@nacds.org
March 13-15, 2011 NACDS Supply Chain & Logistics Conference
San Diego, CA
Contact:
P.O. Box 34814
Alexandria, VA 22334-0814
703-683-5678
March 25-28, 2011 American Pharmacists Annual Meeting
Seattle, WA
Contact:
2215 Constitution Avenue, NW
Washington, DC 20037
Phone: 1-800-237-2742 (APhA)
Fax: 202-448-8734
|
|
|
|
Contact Us |
Contact a Drug Topics editor Click Here
Contact a Drug Topics sales representative Click Here
Learn about direct mail, reprints and classifieds in Drug Topics Click Here |
You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.
To ensure delivery to your inbox, please add us to your address book. If you need help doing this, Click here.
Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 866-529-2922 at any time, or
fax us at 218-740-6417. Outside the U.S., please phone 218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.
|
|
